Infertility Market Trends Provides an In-Depth Insight of Growth Factors and Upcoming Trends, Opportunities by Types and Application to 2026
Infertility is a medical condition in which male or female
members are unable to reproduce or have children. Common conditions for the
condition include low sperm motility, genetic deficiencies, and psychological
issues. According to the Centers for Disease Control & Prevention (CDC),
close to 6% unmarried women are unable to attain pregnancy even after
unprotected intercourse. The global infertility market report compiled by
Market Research Future (MRFR) contains pertinent factors and challenges of customers
as well as efforts of industry stalwarts in easing the process of reproduction.
Market Outlook
The global
Infertility Market Trends is estimated to accrue significant revenue by
exhibiting a CAGR of 4.6% during the forecast period (2017-2023). It stood at
USD 11.2 billion in 2016. Major growth drivers of the market include late
marriages, sedentary lifestyles, genetic deficiencies, environmental factors,
and health history.
Awareness of the condition and preventive measures in terms
of treatment is likely to drive the market growth. Emergence of various clinics
which can conduct tests discreetly can bode well for the market. In addition,
the recognition of infertility as a disease by insurance organizations and
coverage packages being dispensed to patients is a sign of the large potential
of the market. Technological advances in terms of artificial reproduction
technique (ART) and artificial insemination are predicted to bolster the global
infertility market growth. Successful outcomes of such methods as well as
conduction of clinical trials for safe methods of conception among couples are
other major drivers of the market.
High Infertility
treatment costs, side effects of infertility treatment, and societal taboos
are factors which can impede market growth.
Competitive Outlook
SCSA Diagnostics, Inc., Bayer Healthcare, EMD Serono,
Inc., Zydus Cadila Healthcare Ltd, Aetna Inc., Androvia LifeSciences, Andrology
Solutions, Halotech DNA, and others are prominent names within the global
infertility market.
Segmentation Analysis
The global infertility market report is segmented by sex,
diagnosis, drugs, and techniques.
By sex, it is segmented into male, female, and
unexplained.
By diagnosis, it is segmented into men diagnostic
tests, female diagnostic tests, and general diagnostic tests. Testicular
biopsy, genetic testing, semen analysis, and others are major sub-segments
within the men diagnostic tests segment. Female diagnostic tests, on the other
hand, is segmented into hysterosalpingography, hysteroscopy, laparoscopy,
ovulation testing, and others. Microscopic analysis, imaging, hormone testing,
genetic testing, and others are segments within general diagnostic tests.
By drugs, it is segmented into seraphine, clomiphene
citrate, letrozole, hormone treatment, and others.
By techniques, it is segmented into assisted
reproductive technology (ART), surgery, and intrauterine insemination. Surgery
is further segmented into tubal surgeries, laparoscopic or hysteroscopic
surgery, and others.
Regional Analysis
North America, Asia Pacific, Europe, and the Middle East
& Africa (MEA) are the regions being considered for the basis of the
report.
North America is predicted to dominate the market led by the
U.S. Factors facilitating regional market growth include rise in awareness
levels of patients, high expendable income levels of patients, and
reimbursement schemes.
Europe is expected to be the second largest region led by
France, Germany, and the U.K. Changes in lifestyles of patients and delayed
pregnancies are factors which can drive the need for fertility treatments. In
addition, the successful outcomes of fertility clinics as well as rise in
cryopreservation can contribute to the global infertility market growth.
Industry News
Seed funding to accelerate research and development efforts
put into fertility treatments is expected to increase due to successful
outcomes as well as demand for affordable treatment methods. Recently, Mojo is
planning to raise USD 1.8 million in capital with the help of Nordic firm,
Inventure. The firm plans to use robotics and artificial intelligence to assist
in egg and sperm quality analysis as well as develop methods to lower
fertilization costs.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment